The kisspeptin-GnRH pathway in human reproductive health and disease von Skorupskaite, Karolina, George, Jyothis T, Anderson, Richard A

Volltext

Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® t... von Sattar, Naveed, Fitchett, David, Hantel, Stefan, George, Jyothis T., Zinman, Bernard

Volltext

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial von Inzucchi, Silvio E, Zinman, Bernard, Fitchett, David, Wanner, Christoph, Ferrannini, Ele, Schumacher, Martin, Schmoor, Claudia, Ohneberg, Kristin, Johansen, Odd Erik, George, Jyothis T, Hantel, Stefan, Bluhmki, Erich, Lachin, John M

Volltext

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial von Fitchett, David, Inzucchi, Silvio E, Cannon, Christopher P, McGuire, Darren K, Scirica, Benjamin M, Johansen, Odd Erik, Sambevski, Steven, Kaspers, Stefan, Pfarr, Egon, George, Jyothis T, Zinman, Bernard

Volltext

Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial von Fitchett, David, Butler, Javed, van de Borne, Philippe, Zinman, Bernard, Lachin, John M, Wanner, Christoph, Woerle, Hans J, Hantel, Stefan, George, Jyothis T, Johansen, Odd Erik, Inzucchi, Silvio E

Volltext

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial von Rosenstock, Julio, Kahn, Steven E, Johansen, Odd Erik, Zinman, Bernard, Espeland, Mark A, Woerle, Hans J, Pfarr, Egon, Keller, Annett, Mattheus, Michaela, Baanstra, David, Meinicke, Thomas, George, Jyothis T, von Eynatten, Maximilian, McGuire, Darren K, Marx, Nikolaus

Volltext

Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control von Inzucchi, Silvio E, Kosiborod, Mikhail, Fitchett, David, Wanner, Christoph, Hehnke, Uwe, Kaspers, Stefan, George, Jyothis T, Zinman, Bernard

Volltext

Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial von Monteiro, Pedro, Bergenstal, Richard M, Toural, Elvira, Inzucchi, Silvio E, Zinman, Bernard, Hantel, Stefan, Kiš, Sanja Giljanovic, Kaspers, Stefan, George, Jyothis T, Fitchett, David

Volltext

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials von Rosenstock, Julio, Marquard, Jan, Laffel, Lori M, Neubacher, Dietmar, Kaspers, Stefan, Cherney, David Z, Zinman, Bernard, Skyler, Jay S, George, Jyothis, Soleymanlou, Nima, Perkins, Bruce A

Volltext

Cardiovascular Outcomes and Safety of Empagliflozin in Patients With Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME von Verma, Subodh, Mazer, C David, Al-Omran, Mohammed, Inzucchi, Silvio E, Fitchett, David, Hehnke, Uwe, George, Jyothis T, Zinman, Bernard

Volltext

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG... von Verma, Subodh, Mazer, C. David, Fitchett, David, Inzucchi, Silvio E., Pfarr, Egon, George, Jyothis T., Zinman, Bernard

Volltext

Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose‐lowering therapy? von Inzucchi, Silvio E., Fitchett, David, Jurišić‐Eržen, Dubravka, Woo, Vincent, Hantel, Stefan, Janista, Christina, Kaspers, Stefan, George, Jyothis T., Zinman, Bernard

Volltext

Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational Trial von Levin, Adeera, Perkovic, Vlado, Wheeler, David C, Hantel, Stefan, George, Jyothis T, von Eynatten, Maximilian, Koitka-Weber, Audrey, Wanner, Christoph

Volltext

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial von Rosenstock, Julio, Perkovic, Vlado, Johansen, Odd Erik, Cooper, Mark E, Kahn, Steven E, Marx, Nikolaus, Alexander, John H, Pencina, Michael, Toto, Robert D, Wanner, Christoph, Zinman, Bernard, Woerle, Hans Juergen, Baanstra, David, Pfarr, Egon, Schnaidt, Sven, Meinicke, Thomas, George, Jyothis T, von Eynatten, Maximilian, McGuire, Darren K

Volltext

Neurokinin B Regulates Gonadotropin Secretion, Ovarian Follicle Growth, and the Timing of Ovulation in Healthy Women von Skorupskaite, Karolina, George, Jyothis T, Veldhuis, Johannes D, Anderson, Richard A

Volltext

Efficacy of empagliflozin on heart failure and renal outcomes in patients with atrial fibrillation: data from the EMPA‐REG OUTCOME trial von Böhm, Michael, Slawik, Jonathan, Brueckmann, Martina, Mattheus, Michaela, George, Jyothis T., Ofstad, Anne Pernille, Inzucchi, Silvio E., Fitchett, David, Anker, Stefan D., Marx, Nikolaus, Wanner, Christoph, Zinman, Bernard, Verma, Subodh

Volltext

Empagliflozin in women with type 2 diabetes and cardiovascular disease – an analysis of EMPA-REG OUTCOME von Zinman, Bernard, Inzucchi, Silvio E., Wanner, Christoph, Hehnke, Uwe, George, Jyothis T., Johansen, Odd Erik, Fitchett, David

Volltext

Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome von Skorupskaite, Karolina, George, Jyothis T, Veldhuis, Johannes D, Millar, Robert P, Anderson, Richard A

Volltext

FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later von McGuire, Darren K., Marx, Nikolaus, Johansen, Odd Erik, Inzucchi, Silvio E., Rosenstock, Julio, George, Jyothis T.

Volltext

Relationship between hypoglycaemia, cardiovascular outcomes, and empagliflozin treatment in the EMPA-REG OUTCOME® trial von Fitchett, David, Inzucchi, Silvio E, Wanner, Christoph, Mattheus, Michaela, George, Jyothis T, Vedin, Ola, Zinman, Bernard, Johansen, Odd Erik

Volltext